Product Name :
Rovazolac
Description:
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
CAS:
1454288-88-0
Molecular Weight:
452.45
Formula:
C21H19F3N2O4S
Chemical Name:
ethyl 2-(5-3′-methanesulfonyl-[1,1′-biphenyl]-4-yl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
Smiles :
CCOC(=O)CN1N=C(C=C1C1C=CC(=CC=1)C1=CC(=CC=C1)S(C)(=O)=O)C(F)(F)F
InChiKey:
ZUMNJDGBYXHASJ-UHFFFAOYSA-N
InChi :
InChI=1S/C21H19F3N2O4S/c1-3-30-20(27)13-26-18(12-19(25-26)21(22,23)24)15-9-7-14(8-10-15)16-5-4-6-17(11-16)31(2,28)29/h4-12H,3,13H2,1-2H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.|Product information|CAS Number: 1454288-88-0|Molecular Weight: 452.45|Formula: C21H19F3N2O4S|Chemical Name: ethyl 2-(5-3′-methanesulfonyl-[1,1′-biphenyl]-4-yl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate|Smiles: CCOC(=O)CN1N=C(C=C1C1C=CC(=CC=1)C1=CC(=CC=C1)S(C)(=O)=O)C(F)(F)F|InChiKey: ZUMNJDGBYXHASJ-UHFFFAOYSA-N|InChi: InChI=1S/C21H19F3N2O4S/c1-3-30-20(27)13-26-18(12-19(25-26)21(22,23)24)15-9-7-14(8-10-15)16-5-4-6-17(11-16)31(2,28)29/h4-12H,3,13H2,1-2H3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: To be determined|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.Leniolisib Formula |Shelf Life: ≥12 months if stored properly.Gilteritinib Epigenetics |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:33183167 |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Rovazolac is an anti-inflammatory drug candidate.|References:|Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1Products are for research use only. Not for human use.|